In Vitro Diagnostics Market Size to Hit US$ 123.7 Bn by 2030

by NASDAQ Market News January 3, 2022

NASDAQ Market News
Click here to email author

Radiomedix and Orano Med Announce the Initiation of the Phase II Multi-Center Clinical Trial of Alphamedix™ for Targeted Alpha-Emitter Therapy of Neuroendocrine Cancers

Powerful Medical launches the historically first medical device clinical trial under the new EU Medical Device Regulation in Slovakia in cooperation with two of Slovakia’s largest private health insurers, Union (Achmea B.V.) and Dôvera

Ads